Product Information

GABAPENTIN 800 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0860 per EA under NDC 16571011750. Its NADAC has been published 142 times since Feb 28, 2024.

FDA first approved this application on Jul 19, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 800 MG TABLET

Gabapentin
$0.0860per EA

Strength

800 mg/1

NDC

16571011750

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA217995

FDA Approved

7/19/2023

TE Code

AB1

On Market Since

7/19/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 800 MG TABLET has been published 142 times since Feb 28, 2024, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0860 per EA
All-time high$0.1235 (Mar 13, 2024)
All-time low$0.0799 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0860
Median price$0.1015
Average price$0.1010
Largest weekly change-27.0% (Nov 20, 2024)
Weeks tracked142
Tracking sinceFeb 28, 2024

Price History

1W

0.0%

1M

-2.6%

3M

-8.3%

6M

-12.8%

1Y

-15.4%

3Y

N/A

5Y

N/A

All

-30.4%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0860 per EA (NDC 16571011750), effective Nov 11, 2026.

How has the price of GABAPENTIN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 30.4%. It has been tracked across 142 weekly CMS publications since Feb 28, 2024.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?

Since Feb 28, 2024, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1235 (Mar 13, 2024), with a median of $0.1015 per EA.

Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?

21 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 800 MG TABLET?

GABAPENTIN 800 MG TABLET (NDC 16571011750) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.